期刊文献+

年轻女性子宫内膜癌25例分析 被引量:3

Analysis of 25 cases of endometrial cancer in young females
下载PDF
导出
摘要 目的探讨年轻女性子宫内膜癌临床发病特点,探讨预防、早期诊断及合理治疗方法。方法回顾性分析1993年3月~2006年12月该院治疗的子宫内膜癌患者的临床资料,以其中25例年轻女性患者(≤40岁)为病例组,以248例50岁以上患者为对照组,进行病例对照研究。结果病例组月经不调15例(60%),不孕8例(32%),对照组既往月经不调38例(15.3%),不孕6例(2.4%),差异均有显著性(P<0.001)。病例组子宫内膜样腺癌占96%,其中细胞高分化13例(52%),中分化11例(44%),低分化1例(4%)。ER(+)19例(79.1%),PR(+)21例(87.5%)。对照组子宫内膜样腺癌占68.4%,细胞高分化23例(13.6%),中分化114例(67.4%),低分化32例(18.9%)。ER(+)86例(50.8%),PR(+)92例(54.3%)。差异均有显著性(P<0.001)。病例组中Ⅰ期患者20例(80%),对照组Ⅰ期患者125例(50.2%)。差异有显著性(P<0.01)。结论年轻患者更多有月经不调、不孕、多囊卵巢综合征。发病期别早,细胞高分化,主要为激素依赖型。临床治疗效果好,预后好,早期低危型年轻患者可以考虑保留卵巢功能及生育功能。积极治疗月经失调应该对年轻子宫内膜癌的发生起到一定预防作用。 Objectives To discuss the clinical features, prevention measures, early diagnosis and reasonable therapy of endometrial cancer in young females.Methodsclinical data of in-patients with endometrial cancer from March 1993 to December 2006 were analysed retrospectively.25 of the in-patients with endometrial cancer who were younger than 40-year-old were concluded as group and 248 in-patients who were older than 50 as control group.Case-control study was applied.ResultsThe number of patients complicated with men...
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2008年第20期3053-3055,3062,共4页 China Journal of Modern Medicine
关键词 子宫内膜肿瘤 年龄因素 卵巢功能 预防 endometrial cancer age factor ovarian function prevention
  • 相关文献

参考文献2

二级参考文献18

  • 1尹雪彬,沈铿,郎景和.子宫内膜癌的病理分类、治疗及预后影响因素的现代观[J].中华妇产科杂志,1996,31(8):508-511. 被引量:23
  • 2Nakanishi T,Ishikawa H,Suznki Y,et al.Association between menopausal state and prognosis of endometrial cancer[J].Int J Gynecol Cancer,2001,11(6):483-487.
  • 3Matlock DL,Saleem FA.Charles HE,et al.Synchronous multiple primary neoplasms of the upper females genital tract [J].Gynecol Oncol,1982,13:384.
  • 4Greven KM,Lanciano RM,Corn BW,et al.Pathologic stage endometrial carcinoma:prognostic factors and patterns of recurrence[J]. Cancer,1993,71:3687.
  • 5Gitsch G,Hanzal E,Jensen D,et al.Endometrial cancer in premenopausal women 45 years and younger[J].Obstet Gynecol,1995,85:504.
  • 6Thigpen JT,Brady MF,Alvarez RD,et al.Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma:a dose-response study by the Gynecologic Oncology Group[J].J Clin Oncol,1999,17(6):1736-1744.
  • 7Imai M,Jobo T,Sato R,et al.Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations[J].Eur J Gynaecol Oncol,2001,22(3):217-220.
  • 8Kinster RW.Histological effects of progestins on hyperplasia and carcinoma in situ of the endometrium[J].Cancer,1959,12:1106-1122.
  • 9Kauppila A,Gronroos M,Nieminen U.Clinical outcome in endometrial cancer[J].Obstet Gynecol,1982,60(4):473-480.
  • 10Lewis GC,Slack NH,Mortel R,et al.Adjuvant progestogen therapy in the primary definitive treatment of endometrial cancer[J].Gynecol Oncol,1974,2(2-3):368-376.

共引文献11

同被引文献16

  • 1Neale RE, Darlington S, Murphy MF, et al. The effects of twins, parity and age at first birth on cancer risk in Swedish women. Twin Res Hum Genet,2005, 8(2) : 156-162.
  • 2Bravi F, Scotti L, Bosetti C, Zucchetto A, et al. Food groups and endometrial cancerrisk: a case-control study from Italy. Obstet Gynecol,2009,200 (3) : 1-7.
  • 3Yeh M, Moysich KB, Jayaprakash V,et al. Higher intakes of vegetables and vegetable-related nutrients are associated with lower endometrial cancer risks. Nutr, 2009,139 ( 2 ) : 317-322.
  • 4Yasuda M, Terai Y, Sekijima T, et al. Successful pregnancy after conservative surgery for stage IA endometrial cancer in a young woman. Fertil Steri ,2009,91 (3) :936.
  • 5Patsner B. Endometrial cancer in women of 45 years old or younger[J]. Fur J Gynaecol Oncol ,2002,21(3) :249-250.
  • 6Gunter KD, Fischer C. Gene expression profile in endometri-old endometrial carcinoma[J]. Gynecol Oncol ,2001,83: 175-176.
  • 7Liao X, 5iu MK, Chan KY, et al, Hypermethylation of RAS effector related genes and DNA methyltransferase 1 expression in endometrial carcinogenesis[J]. Int J Cancer ,2008,123(2) : 296-302.
  • 8Dobrzycka B, Terlikowski SJ, Mazurek A, et al . Circulating free DNA, p53 antibody and mutations of KRAS gene in endo metrial cancer[J]. Inl J Cancer ,2010,127(3) :612-621.
  • 9Esteller M,Garcia A, Martinez Palones JM, a al . The clinieo- pathological significance of K-RAS point mutation and gene amplification in endometrial cancer[J]. Eur J Cancer , 1997,33 (10) : 1572-1577.
  • 10Fishel R, Lescoe MK, Ran MR, et al. The human mutator gene homolog MSH2 and its association with hereditary non-polyposis colon cancer[J]. Cell , 1993,75(5) : 1027-1038.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部